Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Coronavirus Update:What patients and families need to know

Participants Needed for Asthma Prevention Study

January 22, 2019

The Children's National IMPACT DC team is conducting the ORBEX study to assess the effectiveness of a medication in the prevention of infant wheezing. We are looking for healthy babies age 5-17 months who are at risk for developing asthma (as defined by having a parent or sibling over 4 years of age with asthma or eczema).

For more information, visit breatheeasyearly.info or contact:

Trisha Ibeh
Study Coordinator
Phone: 202-476-2628